A share price of Astrazeneca plc ADR [AZN] is currently trading at $72.36, up 2.01%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AZN shares have gain 1.57% over the last week, with a monthly amount glided 8.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Astrazeneca plc ADR [NASDAQ: AZN] stock has seen the most recent analyst activity on November 20, 2024, when UBS upgraded its rating to a Neutral. Previously, Deutsche Bank upgraded its rating to Hold on November 06, 2024. On September 13, 2024, downgrade downgraded it’s rating to Sell. Goldman started tracking the stock assigning a Buy rating and suggested a price target of $97 on May 30, 2024. Deutsche Bank upgraded its rating to a Hold. Deutsche Bank downgraded its rating to Sell for this stock on February 08, 2024. In a note dated January 23, 2024, Morgan Stanley initiated an Overweight rating and provided a target price of $85 on this stock.
Astrazeneca plc ADR experienced fluctuations in its stock price throughout the past year between $60.47 and $87.68. Currently, Wall Street analysts expect the stock to reach $88 within the next 12 months. Astrazeneca plc ADR [NASDAQ: AZN] shares were valued at $72.36 at the most recent close of the market. An investor can expect a potential return of 21.61% based on the average AZN price forecast.
Analyzing the AZN fundamentals
Trailing Twelve Months sales for Astrazeneca plc ADR [NASDAQ:AZN] were 54.07B which represents 23.84% growth. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.17 and Total Capital is 0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 71.34 points at the first support level, and at 70.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 74.00, and for the 2nd resistance point, it is at 75.63.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Astrazeneca plc ADR [NASDAQ:AZN] is 0.93. Also, the Quick Ratio is 0.74, while the Cash Ratio stands at 0.19. Considering the valuation of this stock, the price to sales ratio is 4.15, the price to book ratio is 5.51 and price to earnings (TTM) ratio is 32.11.
